Señales en vivo de DXCM | Maximiza tus Ganancias con Getagraph.com

VENDER 71 min ago

@ $129.13

Emitido: 6 may 2024 @ 13:39

Retorno: -0.15%

Señal anterior: may 3 - 15:43

Señal anterior: Comprar

Retorno: 0.53 %

Live Chart Being Loaded With Signals

Commentary (6 may 2024 @ 14:50):
Our systems believe the stock currently is undervalued by 0.54% compare to its pairs and should correct upwards.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally...

Stats
Volumen de hoy	670 495
Volumen promedio	3.24M
Capitalización de mercado	51.27B
EPS	$0 ( 2024-04-25 )
Próxima fecha de ganancias	( $0.390 ) 2024-07-25
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	83.72
ATR14	$2.15 (1.67%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-30	Brown Michael Jon	Sell	629	Common Stock
2024-04-15	Dolan Matthew Vincent	Sell	1 990	Common Stock
2024-04-08	Sayer Kevin R	Sell	27 272	Common Stock
2024-04-08	Sayer Kevin R	Sell	22 361	Common Stock
2024-03-28	Brown Michael Jon	Sell	2 524	Common Stock

INSIDER POWER
-3.71
Last 99 transactions
Buy: 330 077 \| Sell: 350 609

Correlación (AI algo v.1.1b): Undervalued: 0.54% $129.63 paired level. (El Algoritmo Rastrea Los Cambios De Las Acciones Más Correlacionadas En Tiempo Real Y Proporciona Una Actualización Instantánea)

Volumen Correlación

Largo: 0.36 (neutral)

Corto: 0.90 (very strong)

Signal:(42) Expect same movement, but be aware

DexCom Inc Correlación

10 Correlaciones Más Positivas
CAPR	0.859
KRYS	0.848
STER	0.843
MRVI	0.837
DWAC	0.835
HCWB	0.834
ACMR	0.83
DWACU	0.822
SVBI	0.821
LZ	0.82

10 Correlaciones Más Negativas
RILYH	-0.83
NERV	-0.824
HNVR	-0.805
QTEK	-0.802

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

DexCom Inc Correlación - Moneda/Commodity

0.13
( neutral )

0.42
( neutral )

0.00
( neutral )

-0.40
( neutral )

-0.56
( weak negative )

0.58
( weak )

DexCom Inc Finanzas

Annual	2023
Ingresos:	$3.62B
Beneficio Bruto:	$2.29B (63.19 %)
EPS:	$1.400

FY	2023
Ingresos:	$3.62B
Beneficio Bruto:	$2.29B (63.19 %)
EPS:	$1.400

FY	2022
Ingresos:	$2.91B
Beneficio Bruto:	$1.88B (64.72 %)
EPS:	$0.880

FY	2021
Ingresos:	$2.45B
Beneficio Bruto:	$1.68B (68.63 %)
EPS:	$0.400

Financial Reports:

No articles found.

DexCom Inc

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.